Selecta Biosciences (SELB) Financials

$0.75

$0.03 (4.51%)

As on 26-Dec-2023 09:30EDT

Market cap

$-- Mln

Revenue (TTM)

$35 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	34.53	110.78	85.08	16.60	6.68	0.90
Cost of Revenue	--	--	--	--	42.74	47.69
Gross Profit	34.53	110.78	85.08	16.60	6.68	0.90
Operating Expenses	93.11	96.24	89.67	73.42	59.13	65.93
Operating Profit (EBIT)	-58.58	14.54	-4.60	-56.82	-52.46	-65.02
Other Income	12.43	23.26	-2.28	-10.50	--	--
Profit before Tax	-36.45	34.77	-9.72	-68.88	-55.35	-65.34
Provision for Tax	4.61	-0.61	15.97	0.91	-1.81	1.18
Profit after Tax (Net Income)	-40.25	35.38	-25.69	-69.79	-53.54	-65.34
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-27.16	35.38	-25.69	-68.88	-55.35	-65.34

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	60.33	93.83	22.52	-18.01	8.40	-5.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	25.77	46.98	65.11	101.89	56.23	14.76
Current Liabilities	19.94	25.08	72.25	81.55	34.94	35.14
Total Liabilities	125.97	165.89	159.88	165.44	99.57	44.48

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	16.17	17.75	15.44	14.09	2.90	2.41
Current Assets	89.87	148.14	144.44	151.34	96.67	42.08
Total Assets	125.97	165.89	159.88	165.44	99.57	44.48
Total Debt*	10.48	37.93	35.28	35.35	19.28	21.39
Net Current Assets	69.93	123.06	72.19	69.80	61.72	6.93

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-31.63	-60.38	34.88	-51.44	-59.16
Cash Flow from Investing Activities	--	-15.00	-17.14	-0.74	0.23	25.27
Cash from Financing Activities	--	39.22	52.90	14.43	105.04	0.70
Net Cash Inflow / Outflow	--	-7.42	-24.63	48.51	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	37.33	-68.37	-310.05	-245.35	-147.12
ROE (%)	-59.67	60.82	-1,137.85	1,452.53	-3,594.23	-281.64
ROA (%)	-24.54	21.72	-15.79	-52.67	-74.33	-89.76
EBIT Margin (%)	-169.47	13.12	-5.40	-342.36	-785.61	-7,307.53
Net Margin (%)	-85.70	26.39	-31.02	-1,144.42	-801.80	-7,235.44
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-72.13	0.30	4.13	1.49	6.39	3.36
EBIT Growth (%)	-321.97	416.25	91.91	-8.32	20.51	-2.01
Net Profit Growth (%)	-173.89	237.73	63.19	-30.36	18.06	-0.02
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-5.98	20.25	1.82	1.31	0.25
Close Price ($)	0.53	0.57	1.63	1.52	1.19	1.33
High Price ($)	1.00	1.69	2.85	2.42	1.67	8.27
Low Price ($)	0.45	0.32	1.34	0.71	0.64	1.31
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.40	1.57	-1.96	2.30	-3.95
Short term debt to equity ratio	0.03	0.11	0.31	-0.05	2.30	-3.95
Current Ratio	4.51	5.91	2.00	1.86	2.77	1.20
Quick Ratio	4.51	--	--	--	--	--
Interest Coverage	-9.01	4.80	-1.62	-36.52	-34.53	-44.17

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	19.61	8.81	11.65	43.53	74.88	--
Asset Turnover	0.21	0.68	0.52	0.13	0.09	0.01
Receivable days	--	32.43	36.79	134.51	273.51	25.48
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	6.84	10.36
Cash Conversion Cycle	--	--	--	--	--	15.12

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.